• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于食物的数字化教育辅助生活方式干预方案改善 2 型糖尿病患者的胰岛素敏感性、肝脏脂肪变性和纤维化:一项可行性研究。

Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study.

机构信息

Institute for Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.

German Center for Diabetes Research (DZD), München-Neuherberg, Germany.

出版信息

Eur J Nutr. 2021 Oct;60(7):3811-3818. doi: 10.1007/s00394-021-02521-3. Epub 2021 Apr 11.

DOI:10.1007/s00394-021-02521-3
PMID:33839905
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8437928/
Abstract

PURPOSE

Recent trials demonstrated remission of type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) following formula diet-induced weight loss. To improve the outreach for populations in need, many mobile health apps targeting weight loss have been developed with limited scientific evaluation of these apps. The present feasibility study investigated the effects of a novel approach incorporating a regular 'whole food-based' low-calorie diet combined with app-based digital education and behavioral change program on glucose metabolism and disease management.

METHODS

Twenty-four individuals with type 2 diabetes followed this approach supported by weekly coaching calls for 12 weeks. Phenotyping included bioimpedance analysis, mixed-meal tolerance test, magnetic resonance spectroscopy and transient elastography for assessing liver fat content and liver stiffness.

RESULTS

Over 12 weeks, participants reduced their body weight by 9% (97 ± 13 to 88 ± 12 kg), body mass index (BMI; 33 ± 5 to 29 ± 4 kg/m), total fat mass (31 ± 10 to 27 ± 10%) (all p < 0.01) and liver fat by 50% alongside with decreased liver stiffness. Target HbA1c (< 6.5%) was achieved by 38% and resolution of NAFLD (liver fat content < 5.6%) was observed in 30% of the participants.

CONCLUSION

This novel approach combining digital education with a low-calorie diet results in effective improvements of body weight, glycemic control and NAFLD and could complement existing care for patients with type 2 diabetes.

TRIAL REGISTRATION

NCT04509245.

摘要

目的

最近的试验表明,通过配方饮食诱导的体重减轻可以缓解 2 型糖尿病和非酒精性脂肪性肝病(NAFLD)。为了扩大有需要的人群的受益面,许多针对减肥的移动健康应用程序已经开发出来,但这些应用程序的科学评估有限。本可行性研究调查了一种新方法的效果,该方法将常规的“全食物基础”低热量饮食与基于应用程序的数字教育和行为改变计划相结合,对葡萄糖代谢和疾病管理产生影响。

方法

24 例 2 型糖尿病患者采用这种方法,在 12 周内每周接受一次电话咨询。表型分析包括生物阻抗分析、混合餐耐量试验、磁共振波谱和瞬态弹性成像,以评估肝脂肪含量和肝硬度。

结果

在 12 周内,参与者的体重减轻了 9%(97±13 至 88±12 千克),体重指数(BMI;33±5 至 29±4 千克/米),总脂肪量(31±10 至 27±10%)(均 p<0.01),肝脂肪减少了 50%,同时肝硬度降低。38%的患者达到了目标 HbA1c(<6.5%),30%的患者实现了 NAFLD(肝脂肪含量<5.6%)的缓解。

结论

这种将数字教育与低热量饮食相结合的新方法可有效改善体重、血糖控制和 NAFLD,可作为 2 型糖尿病患者现有治疗方法的补充。

临床试验注册

NCT04509245。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/1e8b1431aa2f/394_2021_2521_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/86964678d4a0/394_2021_2521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/548606933e3d/394_2021_2521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/1e8b1431aa2f/394_2021_2521_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/86964678d4a0/394_2021_2521_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/548606933e3d/394_2021_2521_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb78/8437928/1e8b1431aa2f/394_2021_2521_Fig3_HTML.jpg

相似文献

1
Improving insulin sensitivity, liver steatosis and fibrosis in type 2 diabetes by a food-based digital education-assisted lifestyle intervention program: a feasibility study.通过基于食物的数字化教育辅助生活方式干预方案改善 2 型糖尿病患者的胰岛素敏感性、肝脏脂肪变性和纤维化:一项可行性研究。
Eur J Nutr. 2021 Oct;60(7):3811-3818. doi: 10.1007/s00394-021-02521-3. Epub 2021 Apr 11.
2
User Engagement, Acceptability, and Clinical Markers in a Digital Health Program for Nonalcoholic Fatty Liver Disease: Prospective, Single-Arm Feasibility Study.非酒精性脂肪性肝病数字健康项目中的用户参与度、可接受性及临床指标:前瞻性单臂可行性研究
JMIR Cardio. 2024 Feb 15;8:e52576. doi: 10.2196/52576.
3
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
4
Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.热量相同的动物蛋白或植物蛋白饮食可减少 2 型糖尿病患者的肝脏脂肪和炎症。
Gastroenterology. 2017 Feb;152(3):571-585.e8. doi: 10.1053/j.gastro.2016.10.007. Epub 2016 Oct 17.
5
Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.生活方式干预对非肥胖非酒精性脂肪性肝病患者的有益影响。
J Hepatol. 2018 Dec;69(6):1349-1356. doi: 10.1016/j.jhep.2018.08.011. Epub 2018 Aug 22.
6
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.评估钠-葡萄糖共转运蛋白 2 抑制剂达格列净对 2 型糖尿病合并非酒精性脂肪性肝病患者肝脂肪变性和纤维化的影响:应用瞬时弹性成像技术。
Diabetes Obes Metab. 2019 Feb;21(2):285-292. doi: 10.1111/dom.13520. Epub 2018 Oct 2.
7
Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.2 型糖尿病患者非酒精性脂肪性肝病相关肝纤维化的危险因素。
Acta Diabetol. 2019 Nov;56(11):1199-1207. doi: 10.1007/s00592-019-01374-x. Epub 2019 Jun 13.
8
An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.基于互联网的非酒精性脂肪性肝病患者生活方式改变方法:对体重减轻和替代标志物的两年影响。
J Hepatol. 2018 Nov;69(5):1155-1163. doi: 10.1016/j.jhep.2018.07.013. Epub 2018 Oct 2.
9
Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.数字干预结合生活方式教练支持,针对非酒精性脂肪性肝病成年人的饮食和身体活动行为:使用干预映射方法对 VITALISE 进行系统的开发过程。
J Med Internet Res. 2021 Jan 15;23(1):e20491. doi: 10.2196/20491.
10
Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association.非酒精性脂肪性肝病与 2 型糖尿病:韩国糖尿病协会脂肪肝病研究组立场声明。
Diabetes Metab J. 2020 Jun;44(3):382-401. doi: 10.4093/dmj.2020.0010. Epub 2020 May 11.

引用本文的文献

1
Current Situation and Prospects of Digital Therapeutics in the Field of Liver Diseases in China.中国肝脏疾病领域数字疗法的现状与展望
Adv Ther. 2025 Jun;42(6):2639-2658. doi: 10.1007/s12325-024-03086-3. Epub 2025 Apr 18.
2
[Impact of educational intervention in a population with type 2 diabetes mellitus].[教育干预对2型糖尿病患者群体的影响]
Rev Fac Cien Med Univ Nac Cordoba. 2024 Dec 13;81(4):752-767. doi: 10.31053/1853.0605.v81.n4.44579.
3
Navigating Diabetes: Enhancing Self-Management through Education among Diabetic People at the Early Stages of the Disease-A Systematic Review.

本文引用的文献

1
8. Obesity Management for the Treatment of Type 2 Diabetes: .8. 肥胖症管理用于治疗 2 型糖尿病: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S100-S110. doi: 10.2337/dc21-S008.
2
Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus.新发1型和2型糖尿病患者肝脏能量代谢和脂质含量的早期变化
J Hepatol. 2021 May;74(5):1028-1037. doi: 10.1016/j.jhep.2020.11.030. Epub 2020 Nov 28.
3
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans.非酒精性脂肪性肝病(NAFLD):从发病机制到人类治疗理念。
糖尿病管理:通过教育提高早期糖尿病患者的自我管理能力——系统评价。
Int J Environ Res Public Health. 2024 Apr 23;21(5):522. doi: 10.3390/ijerph21050522.
4
The Key Digital Tool Features of Complex Telehealth Interventions Used for Type 2 Diabetes Self-Management and Monitoring With Health Professional Involvement: Scoping Review.用于2型糖尿病自我管理和监测并涉及医疗专业人员的复杂远程医疗干预措施的关键数字工具特征:范围综述
JMIR Med Inform. 2024 Mar 13;12:e46699. doi: 10.2196/46699.
5
A Review of the Epidemiology, Pathophysiology, and Efficacy of Anti-diabetic Drugs Used in the Treatment of Nonalcoholic Fatty Liver Disease.抗糖尿病药物治疗非酒精性脂肪性肝病的流行病学、病理生理学和疗效评价。
Dig Dis Sci. 2021 Nov;66(11):3676-3688. doi: 10.1007/s10620-021-07206-9. Epub 2021 Aug 19.
Mol Metab. 2021 Aug;50:101122. doi: 10.1016/j.molmet.2020.101122. Epub 2020 Nov 19.
4
Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes.载脂蛋白样磷脂酶域蛋白 3 基因在糖尿病患者肝脏脂质含量和胰岛素抵抗中的作用。
Diabetes Care. 2020 Sep;43(9):2161-2168. doi: 10.2337/dc20-0329. Epub 2020 Jun 19.
5
Obesity in adults: a clinical practice guideline.成人肥胖:临床实践指南。
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
6
Mobile Apps for Weight Management: A Review of the Latest Evidence to Inform Practice.移动应用程序在体重管理中的应用:最新证据综述,以指导实践。
Front Endocrinol (Lausanne). 2020 Jun 24;11:412. doi: 10.3389/fendo.2020.00412. eCollection 2020.
7
Nutrition Management Strategies for Nonalcoholic Fatty Liver Disease: Treatment and Prevention.非酒精性脂肪性肝病的营养管理策略:治疗与预防
Clin Liver Dis (Hoboken). 2020 May 7;15(4):144-148. doi: 10.1002/cld.918. eCollection 2020 Apr.
8
Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.2020年非酒精性脂肪性肝病:疾病现状
Gastroenterology. 2020 May;158(7):1851-1864. doi: 10.1053/j.gastro.2020.01.052. Epub 2020 Feb 13.
9
The integrative biology of type 2 diabetes.2 型糖尿病的综合生物学。
Nature. 2019 Dec;576(7785):51-60. doi: 10.1038/s41586-019-1797-8. Epub 2019 Dec 4.
10
Are Lifestyle Therapies Effective for NAFLD Treatment?生活方式疗法对非酒精性脂肪性肝病治疗有效吗?
Trends Endocrinol Metab. 2019 Oct;30(10):701-709. doi: 10.1016/j.tem.2019.07.013. Epub 2019 Aug 15.